Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Cash & Equivalents: 2014-2024

Historic Cash & Equivalents for Ocugen (OCGN) over the last 10 years, with Jun 2024 value amounting to $15.7 million.

  • Ocugen's Cash & Equivalents fell 77.76% to $15.7 million in Q2 2024 from the same period last year, while for Jun 2024 it was $15.7 million, marking a year-over-year decrease of 77.76%. This contributed to the annual value of $39.5 million for FY2023, which is 49.12% down from last year.
  • Latest data reveals that Ocugen reported Cash & Equivalents of $15.7 million as of Q2 2024, which was down 40.54% from $26.4 million recorded in Q1 2024.
  • In the past 5 years, Ocugen's Cash & Equivalents ranged from a high of $129.8 million in Q1 2022 and a low of $3.2 million during Q1 2020.
  • Its 3-year average for Cash & Equivalents is $69.8 million, with a median of $69.4 million in 2023.
  • In the last 5 years, Ocugen's Cash & Equivalents spiked by 2,106.07% in 2020 and then tumbled by 77.76% in 2024.
  • Quarterly analysis of 5 years shows Ocugen's Cash & Equivalents stood at $24.0 million in 2020, then skyrocketed by 295.02% to $95.0 million in 2021, then declined by 18.32% to $77.6 million in 2022, then crashed by 49.12% to $39.5 million in 2023, then tumbled by 77.76% to $15.7 million in 2024.
  • Its Cash & Equivalents stands at $15.7 million for Q2 2024, versus $26.4 million for Q1 2024 and $39.5 million for Q4 2023.